相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer
Moon Jae Chung et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
An update on new adoptive immunotherapy strategies for solid tumors with cytokine-induced killer cells
Clara E. Jaekel et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2014)
Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses
Nicole Joller et al.
IMMUNITY (2014)
DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins
Lucas Ferrari de Andrade et al.
IMMUNOLOGY AND CELL BIOLOGY (2014)
T-cell Immunoglobulin and ITIM Domain (TIGIT) Receptor/Poliovirus Receptor (PVR) Ligand Engagement Suppresses Interferon-γ Production of Natural Killer Cells via β-Arrestin 2-mediated Negative Signaling
Man Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
Eugene D. Kwon et al.
LANCET ONCOLOGY (2014)
Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR
Noa Stanietsky et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Agonistic Anti-TIGIT Treatment Inhibits T Cell Responses in LDLr Deficient Mice without Affecting Atherosclerotic Lesion Development
Amanda C. Foks et al.
PLOS ONE (2013)
Immune-Mediated Adverse Events Associated with Ipilimumab CTLA-4 Blockade Therapy: The Underlying Mechanisms and Clinical Management
Ahmad Tarhini
SCIENTIFICA (2013)
Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study
Runmei Li et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer
Liangrong Shi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Randomized Study of Autologous Cytokine-Induced Killer Cell Immunotherapy in Metastatic Renal Carcinoma
Liang Liu et al.
CLINICAL CANCER RESEARCH (2012)
A phase I/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remission
Yeh-Ching Linn et al.
CYTOTHERAPY (2012)
The TIGIT/CD226 Axis Regulates Human T Cell Function
Ester Lozano et al.
JOURNAL OF IMMUNOLOGY (2012)
A conditionally replicating adenovirus carrying interleukin-24 sensitizes melanoma cells to radiotherapy via apoptosis
Guan Jiang et al.
MOLECULAR ONCOLOGY (2012)
Structure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell-cell adhesion and signaling mechanism that requires cis-trans receptor clustering
Katharina F. Stengel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Potent Antitumor Effect Elicited by RGD-mda-7, an mda-7/IL-24 Mutant, via Targeting the Integrin Receptor of Tumor Cells
Bao-Fu Zhang et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2011)
Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer
Runbo Zhong et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Vstm3 is a member of the CD28 family and an important modulator of T-cell function
Steven D. Levin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
Nicole Joller et al.
JOURNAL OF IMMUNOLOGY (2011)
DNAM-1/CD155 Interactions Promote Cytokine and NK Cell-Mediated Suppression of Poorly Immunogenic Melanoma Metastases
Christopher J. Chan et al.
JOURNAL OF IMMUNOLOGY (2010)
A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma
Hui Dong et al.
DIGESTIVE AND LIVER DISEASE (2009)
Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trial
Paola Olioso et al.
HEMATOLOGICAL ONCOLOGY (2009)
Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell
Yeh C. Linn et al.
IMMUNOLOGY (2009)
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
Xin Yu et al.
NATURE IMMUNOLOGY (2009)
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
Noa Stanietsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers
Dario Sangiolo et al.
INTERNATIONAL IMMUNOLOGY (2008)
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study
Martino Introna et al.
HAEMATOLOGICA (2007)
Principles and use of anti-CTLA4 antibody in human cancer immunotherapy
KS Peggs et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
CD155/PVR enhances glioma cell dispersal by regulating adhesion signaling and focal adhesion dynamics
KE Sloan et al.
CANCER RESEARCH (2005)
A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma
T Leemhuis et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: Critical role of DNAX accessory molecule-1-poliovirus receptor interaction
R Castriconi et al.
CANCER RESEARCH (2004)
Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule
C Bottino et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Overexpression of the CD155 gene in human colorectal carcinoma
D Masson et al.
GUT (2001)
分享论文
